Learn More
Medchemexpress LLC Linzagolix | 935283-04-8 | 99.7% | 508.4 g/mol | C22H15F3N2O7S | 5 MG

Supplier: Medchemexpress LLC HY1090935MG
Linzagolix is a non-peptide, orally active gonadotropin-releasing hormone (GnRH) receptor antagonist used in laboratory research into estrogen-dependent conditions such as uterine fibroids, endometriosis, and adenomyosis. Supplied as a small, high-purity solid for research use only (not for human or veterinary use).
- Non-peptide, orally active GnRH antagonist
- Applicable to uterine fibroids, endometriosis, and adenomyosis research
- High chemical purity suitable for analytical and pharmacological studies
- Supplied in a small 5 mg pack for assay development and pilot studies
- Molecular weight 508.4 g/mol
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.